H.R. 4764 · 116th Congress

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020

Stage: Passed a chamber
Sponsor: Doris Matsui
Introduced: 2019-10-18
Latest action: 2020-12-14 · Message on Senate action sent to the House.

Votes

h vote 211 · 2020-09-30

On Motion to Suspend the Rules and Pass, as Amended: H R 4764 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act

Passed